Botswana Pharmaceuticals & Healthcare Q4 2018
Botswana’s pharmaceutical market will continue to be dominated by generic medicines, given the low purchasing powerof the country and the government’s commitment to improve access to healthcare. Medicine sales will be limited by weakregulatory framework, a small pensionable population and a highly ruralised community. Despite a potential for growth in theunderdeveloped sector, multinational drugmakers will favour larger markets in the region such as South Africa.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook